sars-cov-2 infection in a psoriatic patient treated with il-23 inhibitor. This article is protected by copyright. All rights reserved.we read with great interest the article entitled ‚ÄúSARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor‚Äù published by Messina F. and Piaserico S. in the JEADV.1 This is the first report of COronaVIrus DIsease 2019 (COVID-19) in a psoriatic patient treated with a biologic. Whilst the authors reported an infection that occurred during therapy with an IL-23 inhibitor, we would like to briefly report one that occurred during therapy with an IL-17 inhibitor.